The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Novo Nordisk Limited .

Filed returns
15
match these filters
Matching filed returns per period 0 1 2 3 5 Sep–Dec 2022: 1 filed returns Jan–Apr 2023: 3 filed returns May–Aug 2023: 4 filed returns Sep–Dec 2023: 1 filed returns Jan–Apr 2024: 1 filed returns May–Aug 2024: 1 filed returns Sep–Dec 2024: 1 filed returns Jan–Apr 2025: 1 filed returns May–Aug 2025: 1 filed returns Sep–Dec 2025: 1 filed returns 2023 2024 2025
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2025 Novo Nordisk Limited Health Proposed Changes to the General Pharmaceutical Legislation (Legislation) 1 On lobbying.ie
May–Aug 2025 Novo Nordisk Limited Health Engagement with Government regarding the life-sciences sector in Ireland and the EU General Pharmaceutical Legislation (GPL). (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2025 Novo Nordisk Limited Health Engagement with Government, MEPs and public officials regarding the life-sciences sector in Ireland and the EU General Pharmaceutical Legislation (GPL) including two roundtable events. (Public policy or programme) 12 On lobbying.ie
Sep–Dec 2024 Novo Nordisk Limited Health Engagement with Government regarding the life-sciences sector in Ireland and the EU General Pharmaceutical Legislation (GPL). (Public policy or programme) 6 On lobbying.ie
May–Aug 2024 Novo Nordisk Limited Health Engagement organised by Novo Nordisk Ireland and IDA Ireland with local Westmeath TD and Minister, Peter Burke, following the acquisition of a manufacturing facility in Athlone. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2024 Novo Nordisk Limited Health Launch of Novo Nordisk Cycle to School initiative, and discussion with Minister of State Jack Chambers regarding the promotion of European competitiveness and the adoption of a life science strategy in Ireland. (Public policy or programme) 3 On lobbying.ie
Sep–Dec 2023 Novo Nordisk Limited Health Launch of Novo Nordisk electric delivery van, and briefing for Minister of State Ossian Smyth regarding Novo Nordisk sustainability initiatives and the importance of an innovative life science ecosystem in Ireland. (Public policy or programme) 2 On lobbying.ie
May–Aug 2023 Novo Nordisk Limited Health To discuss the importance of an innovative life science ecosystem in Ireland, outlining Novo Nordisk position on the revision of the EU General Pharmaceutical Legislation. (Public policy or programme) 1 On lobbying.ie
May–Aug 2023 Novo Nordisk Limited Health Discussions on how Novo Nordisk is managing the green transition and the policy environment for Europe's life-sciences sector. MEP Kelly participated in a European Parliament ITRE (industry) committee delegation to… (Public policy or programme) 1 On lobbying.ie
May–Aug 2023 Novo Nordisk Limited Health Attendance at a Vulcan roundtable discussion with MEPs regarding the future of the pharmaceutical industry in Europe. (Public policy or programme) 1 On lobbying.ie
May–Aug 2023 Novo Nordisk Limited Health To discuss the importance of an innovative life science ecosystem in Ireland, outlining Novo Nordisk position on the revision of the EU General Pharmaceutical Legislation. (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2023 Novo Nordisk Limited Health To discuss the importance of an innovative life science ecosystem in Ireland, outlining Novo Nordisk position on the revision of the EU General Pharmaceutical Legislation. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2023 Novo Nordisk Limited Health To discuss the importance of an innovative life science ecosystem in Ireland, outlining Novo Nordisk position on the revision of the EU General Pharmaceutical Legislation. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2023 Novo Nordisk Limited Health To discuss the importance of an innovative life science ecosystem in Ireland, outlining Novo Nordisk position on the revision of the EU General Pharmaceutical Legislation. (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2022 Novo Nordisk Limited Health To discuss the importance of an innovative ecosystem, including access and reimbursement environment, for a successful life science industry in Ireland to secure our place as a leading life sciences nation for the… (Public policy or programme) 3 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 15 100.0%